Taiwan FDA registration 8b7d1612140277eddf1c5719e7270097
Fuyong Yilimai blood glucose measurement system
TW: 福永易立邁血糖量測系統
Taiwan·Risk Class 2·EPS BIO TECHNOLOGY CORP.·Registered May 02, 2013 – May 02, 2028ActiveRegistration details
- Analysis ID
- 8b7d1612140277eddf1c5719e7270097
Company information
- Manufacturer
- EPS BIO TECHNOLOGY CORP.
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- EPS BIO TECHNOLOGY CORP.
Product details
- Intended Use
- This product is suitable for Ima blood glucose test tablets, which are used to measure the glucose content in fresh microvascular whole blood samples in vitro, and are not suitable for newborn testing.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- Domestic
Dates and status
- Registration Date
- May 02, 2013
- Expiry Date
- May 02, 2028
About this record
Access comprehensive regulatory information for Fuyong Yilimai blood glucose measurement system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 8b7d1612140277eddf1c5719e7270097 and manufactured by EPS BIO TECHNOLOGY CORP.. The authorized representative in Taiwan is EPS BIO TECHNOLOGY CORP..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices